EYR MEDICAL AS

0158 OSLO

Finances

Share Ownership

Return on Equity

−123,07 %

Current Ratio

1,52

Debt-to-Equity Ratio

0,08

Key figures (NOK)	2022	2021	2020	2019
Revenue	18 155 000	15 921 000	13 230 000	13 751 000
Net Income	−24 045 000	−25 642 000	−25 413 000	−6 521 000
Total Assets	30 761 000	55 100 000	38 638 000	12 577 000
Total Equity	19 537 000	43 711 000	24 801 000	−1 866 000

Income (NOK)	2022	2021	2020	2019
Revenue	18 155 000	15 921 000	13 230 000	13 751 000
Expenditure	42 116 000	40 976 000	38 055 000	19 820 000
Operating Profit	−23 960 000	−25 055 000	−24 825 000	−6 069 000
Financial Income	81 000	44 000	157 000	10 000
Financial Costs	166 000	575 000	745 000	463 000
Financial Balance	−85 000	−531 000	−588 000	−453 000
Earnings Before Tax	−24 045 000	−25 586 000	−25 413 000	−6 521 000
Tax	0	56 000	0	0
Net Income	−24 045 000	−25 642 000	−25 413 000	−6 521 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	15 953 000	15 639 000	11 959 000	8 193 000
Total Current Assets	14 807 000	39 461 000	26 679 000	4 384 000
Total Assets	30 761 000	55 100 000	38 638 000	12 577 000
Total Retained Equity	−103 796 000	−79 750 000	−54 108 000	−28 695 000
Total Equity	19 537 000	43 711 000	24 801 000	−1 866 000
Total Long-Term Debt	1 500 000	1 500 000	5 000 000	5 000 000
Total Current Debt	9 723 000	9 890 000	8 837 000	9 443 000
Total Equity and Debt	30 761 000	55 100 000	38 638 000	12 577 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	18 306 000	15 894 000	13 230 000	13 751 000
Other Income	−151 000	27 000	0	0
Revenue	18 155 000	15 921 000	13 230 000	13 751 000
Cost of Goods Sold	10 541 000	7 347 000	6 891 000	3 841 000
Salary Costs	15 852 000	15 231 000	7 730 000	5 782 000
Depreciation	1 131 000	1 131 000	1 112 000	923 000
Impairment	0	0	0	0
Expenditure	42 116 000	40 976 000	38 055 000	19 820 000
Operating Profit	−23 960 000	−25 055 000	−24 825 000	−6 069 000
Financial Income	81 000	44 000	157 000	10 000
Financial Costs	166 000	575 000	745 000	463 000
Financial Balance	−85 000	−531 000	−588 000	−453 000
Dividends	0	0	0	0
Net Income	−24 045 000	−25 642 000	−25 413 000	−6 521 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	930 000	2 041 000	3 153 000	4 264 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	59 000	78 000	97 000	0
Total Tangible Assets	59 000	78 000	97 000	0
Total Fiancial Fixed Assets	14 965 000	13 520 000	8 709 000	3 929 000
Total Fixed Assets	15 953 000	15 639 000	11 959 000	8 193 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	7 505 000	28 587 000	23 159 000	1 905 000
Total Current Assets	14 807 000	39 461 000	26 679 000	4 384 000
Total Assets	30 761 000	55 100 000	38 638 000	12 577 000
Total Equity	19 537 000	43 711 000	24 801 000	−1 866 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	1 500 000	1 500 000	5 000 000	5 000 000
Creditors	5 807 000	5 821 000	6 170 000	4 254 000
Unpaid Taxes	1 141 000	1 425 000	672 000	577 000
Dividends	0	0	0	0
Other Current Debt	2 775 000	2 588 000	1 995 000	4 612 000
Total Current Debt	9 723 000	9 890 000	8 837 000	9 443 000
Total Equity and Debt	30 761 000	55 100 000	38 638 000	12 577 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−123,07 %	−58,66 %	−102,47 %	349,46 %
Debt-to-Equity Ratio	0,08	0,03	0,2	−2,68
Operating Profit Margin	−131,97 %	−157,37 %	−187,64 %	−44,13 %
Current Ratio	1,52	3,99	3,02	0,46
Quick Ratio	1,52	3,99	3,02	0,46
Equity Ratio	0,64	0,79	0,64	−0,15
Gross Profit Margin	41,94 %	53,85 %	47,91 %	72,07 %